Efficacy and Safety of Oral Ritlecitinib for the Treatment of Active Nonsegmental Vitiligo: A Randomized Phase 2b Clinical Trial.
暂无分享，去创建一个
A. Ganesan | M. Picardo | E. Peeva | B. King | J. Bae | K. Ezzedine | A. Pandya | D. Thaçi | I. Hamzavi | A. Banerjee | M. Vincent | Dahong Yu | G. Han | J. Harris | Rodney D Sinclair | Kavita Gandhi | L. Cox | Katsuhiko Tsukamoto | Y. Yamaguchi | A. Sloan